Literature DB >> 11940227

NK cells, MHC class I molecules and the missing self.

K Kärre1.   

Abstract

This article is based on a lecture presented at the Novartis Prize ceremony at the International Congress of Immunology in July 2001. It gives a personal and historical perspective on the research performed by the author and his colleagues during the development and pursuit of the model of 'missing-self recognition' for natural killer (NK) cells. This model is based on the idea that one important function of NK cells is to detect and eliminate cells because they fail to express normal self markers. Further mechanistic models predicted the existence of inhibitory major histocompatibility complex (MHC) class I specific receptors, later identified by the fellow Novartis laureates contributing in this issue. The article covers the first decade (1980-1990) of research on this concept. It discusses factors contributing to the formulation of a hypothesis, the use of predictions and experimental test models, the importance of international collaborations and reagent exchange, and several other aspects that allowed the progression of this research project. Finally, the perspective of today's knowledge is used to discuss some surprising findings where the missing-self hypothesis made the wrong predictions, or at least failed to make the correct ones.

Mesh:

Substances:

Year:  2002        PMID: 11940227     DOI: 10.1046/j.1365-3083.2002.01053.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  91 in total

Review 1.  Generation of natural killer cells from hematopoietic stem cells in vitro for immunotherapy.

Authors:  Martha Luevano; Alejandro Madrigal; Aurore Saudemont
Journal:  Cell Mol Immunol       Date:  2012-06-18       Impact factor: 11.530

Review 2.  Innate immune control of HIV.

Authors:  Mary Carrington; Galit Alter
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

3.  New frontiers in immunology. Workshop on the road ahead: future directions in fundamental and clinical immunology.

Authors:  Bruce Beutler; Jean-Laurent Casanova
Journal:  EMBO Rep       Date:  2005-07       Impact factor: 8.807

4.  CD161B:ClrB interactions mediate activation of enhanced lysis of tumor target cells following NK cell:DC co-culture.

Authors:  Tianbing Yang; Melanie S Flint; Katie M Webb; William H Chambers
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

Review 5.  The role of glycans in immune evasion: the human fetoembryonic defence system hypothesis revisited.

Authors:  Gary F Clark
Journal:  Mol Hum Reprod       Date:  2013-09-15       Impact factor: 4.025

Review 6.  Exploring the NK cell platform for cancer immunotherapy.

Authors:  Jacob A Myers; Jeffrey S Miller
Journal:  Nat Rev Clin Oncol       Date:  2020-09-15       Impact factor: 66.675

Review 7.  The role of CD94/NKG2 in innate and adaptive immunity.

Authors:  Anasuya Gunturi; Rance E Berg; James Forman
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

8.  NKG2D receptor-mediated NK cell function is regulated by inhibitory Ly49 receptors.

Authors:  Jeyarani Regunathan; Yuhong Chen; Demin Wang; Subramaniam Malarkannan
Journal:  Blood       Date:  2004-08-24       Impact factor: 22.113

9.  Regulatory activity of azabisphosphonate-capped dendrimers on human CD4+ T cell proliferation enhances ex-vivo expansion of NK cells from PBMCs for immunotherapy.

Authors:  Damien Portevin; Mary Poupot; Olivier Rolland; Cédric-Olivier Turrin; Jean-Jacques Fournié; Jean-Pierre Majoral; Anne-Marie Caminade; Remy Poupot
Journal:  J Transl Med       Date:  2009-09-24       Impact factor: 5.531

10.  A novel system of polymorphic and diverse NK cell receptors in primates.

Authors:  Anne Averdam; Beatrix Petersen; Cornelia Rosner; Jennifer Neff; Christian Roos; Manfred Eberle; Fabienne Aujard; Claudia Münch; Werner Schempp; Mary Carrington; Takashi Shiina; Hidetoshi Inoko; Florian Knaust; Penny Coggill; Harminder Sehra; Stephan Beck; Laurent Abi-Rached; Richard Reinhardt; Lutz Walter
Journal:  PLoS Genet       Date:  2009-10-16       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.